Literature DB >> 2477244

Identification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant.

J B Rothbard1, R M Pemberton, H C Bodmer, B A Askonas, W R Taylor.   

Abstract

The residues in an influenza nucleoprotein (NP) cytotoxic T cell determinant necessary for cytotoxic T cell (CTL) recognition, were identified by assaying the ability of hybrid peptides to sensitize a target cell to lysis. The hybrid peptides were formed by substituting amino acids from one determinant (influenza NP 147-158) for the corresponding residues of a second peptide (HLA CW3 171-182) capable of binding to a common class I protein (H-2Kd). Six amino acids resulted in partial recognition; however, the presence of a seventh improved the potency of the peptide. Five of the six amino acids were shown to be required for recognition. The spacing of the six amino acids was consistent with the peptide adopting a helical conformation when bound. The importance of each amino acid in CTL recognition and binding to the restriction element was investigated further by assaying the ability of peptides containing point substitutions either to sensitize target cells or to compete with the natural NP sequence for recognition by CTL. The T cell response was much more sensitive to substitution than the ability of the peptide to bind the restriction element. Collectively the separate strategies identified an approximate conformation and orientation of the peptide when part of the complex and permitted a potential location in the MHC binding site to be identified. The model provides a rationalization for analogues which have previously been shown to exhibit greater affinity for the class I molecule and suggests that the binding site in major histocompatibility complex (MHC) class I molecules might have greater steric constraints that the corresponding area of class II proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477244      PMCID: PMC401165          DOI: 10.1002/j.1460-2075.1989.tb08359.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  25 in total

1.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

2.  Immunological self, nonself discrimination.

Authors:  J G Guillet; M Z Lai; T J Briner; S Buus; A Sette; H M Grey; J A Smith; M L Gefter
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

3.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

4.  Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity.

Authors:  H J Zweerink; B A Askonas; D Millican; S A Courtneidge; J J Skehel
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

5.  High-affinity fluorescent peptide binding to I-Ad in lipid membranes.

Authors:  T H Watts; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

6.  Interaction of peptide antigens and class II major histocompatibility complex antigens.

Authors:  J G Guillet; M Z Lai; T J Briner; J A Smith; M L Gefter
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

7.  H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.

Authors:  J L Maryanski; P Pala; G Corradin; B R Jordan; J C Cerottini
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

8.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

Authors:  S Buus; A Sette; S M Colon; D M Jenis; H M Grey
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

9.  Binding of immunogenic peptides to Ia histocompatibility molecules.

Authors:  B P Babbitt; P M Allen; G Matsueda; E Haber; E R Unanue
Journal:  Nature       Date:  1985 Sep 26-Oct 2       Impact factor: 49.962

10.  HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes.

Authors:  A J McMichael; F M Gotch; J Rothbard
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Interactions between immunogenic peptides and HLA-DR molecules.

Authors:  J B Rothbard; R Busch
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins.

Authors:  Guglielmo Lucchese; Giovanni Capone; Darja Kanduc
Journal:  Schizophr Bull       Date:  2013-01-31       Impact factor: 9.306

Review 3.  Synthetic peptides in biochemical research.

Authors:  D C Hancock; N J O'Reilly; G I Evan
Journal:  Mol Biotechnol       Date:  1995-08       Impact factor: 2.695

4.  Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades.

Authors:  A Bertoletti; F Cham; S McAdam; T Rostron; S Rowland-Jones; S Sabally; T Corrah; K Ariyoshi; H Whittle
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia.

Authors:  M Nakagawa; D P Stites; S Farhat; A Judd; A B Moscicki; A J Canchola; J F Hilton; J M Palefsky
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

6.  The Peptide Network between Tetanus Toxin and Human Proteins Associated with Epilepsy.

Authors:  Guglielmo Lucchese; Jean Pierre Spinosa; Darja Kanduc
Journal:  Epilepsy Res Treat       Date:  2014-06-01

7.  Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.

Authors:  A Bertoletti; A Costanzo; F V Chisari; M Levrero; M Artini; A Sette; A Penna; T Giuberti; F Fiaccadori; C Ferrari
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

8.  EBV-Associated Cancer and Autoimmunity: Searching for Therapies.

Authors:  Giovanni Capone; Candida Fasano; Guglielmo Lucchese; Michele Calabrò; Darja Kanduc
Journal:  Vaccines (Basel)       Date:  2015-02-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.